Noom
+25%
est. 2Y upside i
Behavior change and weight management platform using psychology
Rank
#1489
Sector
Digital Health, Healthcare Technology
Est. Liquidity
~2Y
Data Quality
Data: MediumNoom offers a moderate expected upside of ~25% over 2 years, but with significant downside risk from stale valuation and fierce competition.
Last updated: July 19, 2026
Successful IPO within 2 years drives revenue multiple to 6x, yielding $8.13B exit value, netting 100% upside. No dilutive raise needed.
Revenue grows to $1.355B, multiple converges to 4x, exit value $5.42B, 46.5% upside. Preference overhang is moderate.
Revenue falls short or multiple compresses to 2.5x, exit value $3.39B, after preference common recovers $2.67B, -27.9% loss. Incumbent competition and market headwinds persist.
Preference Stack Risk
moderateFunding Intensity
19%Total preferred overhang of $717.8M represents 19.4% of current valuation, moderate drag on common equity.
Dilution Risk
lowNoom is profitable with $1B revenue, unlikely to require dilutive funding within 2 years.
Secondary Liquidity
noneNo secondary market transactions reported; liquidity is limited to IPO or acquisition.
Questions to Ask at the Interview
Strategic questions based on Noom's data — designed to show you've done your homework.
- 1
“How does Noom plan to differentiate its AI coaching from commoditized alternatives?”
- 2
“What is the unit economics of the GLP-1 med program versus traditional subscription?”
- 3
“Given the 2021 valuation and delayed IPO, what is the realistic timeline for liquidity?”
Community
Valuation Sentiment
Our model estimates +25% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.